Xiamen Amoytop Biotech Co., Ltd.
SHH: 688278.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Li Sun
- Employees
- 2,423
- Headquarters
- Xiamen, China
- IPO year
- 2020
- Market cap
- CN¥23.3B
- Website
- https://www.amoytop.com
Loading 688278…
Loading profile data…Frequently asked questions about 688278
What does Xiamen Amoytop Biotech Co., Ltd. (688278.SS) do?
Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs using genetic engineering technology in China. It offers formulations, reagents, and APIs, as well as custom-manufacturing services. The company was founded in 1996 and is based in Xiamen, China.
Where does 688278.SS trade?
Xiamen Amoytop Biotech Co., Ltd. (688278.SS) trades on the Shanghai Stock Exchange.
What sector is 688278.SS in?
Xiamen Amoytop Biotech Co., Ltd. (688278.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Xiamen Amoytop Biotech Co., Ltd.?
Li Sun is the chief executive officer of Xiamen Amoytop Biotech Co., Ltd. (688278.SS).
Where is Xiamen Amoytop Biotech Co., Ltd. headquartered?
Xiamen Amoytop Biotech Co., Ltd. is headquartered in China.
Does 688278.SS pay a dividend?
Yes — Xiamen Amoytop Biotech Co., Ltd. (688278.SS) paid a trailing twelve-month dividend of CNY 0.62 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688278.SS go public?
Xiamen Amoytop Biotech Co., Ltd. (688278.SS) completed its initial public offering in 2020.